Search results
Results from the WOW.Com Content Network
This is a list of investigational sexual dysfunction drugs, or drugs that are currently under development for clinical treatment of sexual dysfunction but are not yet approved. Chemical/generic names are listed first, with developmental code names, synonyms, and brand names in parentheses. This list was last comprehensively updated in June 2017.
Erectile dysfunction (ED), also referred to as impotence, is a form of sexual dysfunction in males characterized by the persistent or recurring inability to achieve or maintain a penile erection with sufficient rigidity and duration for satisfactory sexual activity.
The Best ED Medication for Men: Pros & Cons of Top ED Pills. Over the last 25 years, (ED) medications like Viagra and Cialis have become common fixtures in bedrooms around the world.
[11] [34] The rate of discontinuation of the drug due to adverse effects was less than 5%. [11] A subset of men affected by sexual and mood side effects report persistent loss of libido, [34] depression, [27] and erectile dysfunction for several years after discontinuing treatment. [35]
Besides trazodone alone, a combination of trazodone and bupropion (developmental code names and tentative brand names S1P-104, S1P-205, Lorexys, and Orexa) is under development for the treatment of erectile dysfunction and female sexual dysfunction. [152] [153] [154] As of September 2021, it is in phase 2 clinical trials for these indications ...
When injected into the penis for erectile dysfunction; side effects may include penile pain, bleeding at the site of injection, and prolonged erection (priapism). [2] Prostaglandin E 1 was isolated in 1957 and approved for medical use in the United States in 1981. [2] [6] Misoprostol has various obstetric uses.
However, based on incomplete population based studies from the United States, Europe and Australia, unspecified arousal dysfunction (in which a woman is unable to achieve desirable genital or non-genital sexual arousal despite adequate stimulation and desire) was present in 3-9% of women aged 18–44, 5-7.5% aged 45–64 and 3-6% in women older ...
The most well-known class of drugs used for erectile dysfunction are the Category:PDE5 inhibitors. Subcategories. This category has only the following subcategory. P.